Research ArticleTheranostics
Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of a Novel Radiohybrid PSMA, 18F-rhPSMA-7, in Patients with Prostate Cancer
So Won Oh, Alexander Wurzer, Eugene J. Teoh, Sohee Oh, Thomas Langbein, Markus Krönke, Michael Herz, Saskia Kropf, Hans-Jürgen Wester, Wolfgang A. Weber and Matthias Eiber
Journal of Nuclear Medicine May 2020, 61 (5) 702-709; DOI: https://doi.org/10.2967/jnumed.119.234609
So Won Oh
1Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
2Department of Nuclear Medicine, Seoul National University Boramae Medical Center, Seoul, Korea
Alexander Wurzer
3Technical University of Munich, Garching, Germany
Eugene J. Teoh
4Department of Radiology and Nuclear Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Sohee Oh
5Department of Biostatistics, Seoul National University Boramae Medical Center, Seoul, Korea; and
Thomas Langbein
1Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Markus Krönke
1Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Michael Herz
1Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Saskia Kropf
6Scintomics GmbH, Fuenstenfeldbruck, Germany
Hans-Jürgen Wester
3Technical University of Munich, Garching, Germany
Wolfgang A. Weber
1Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Matthias Eiber
1Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 5
May 1, 2020
Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of a Novel Radiohybrid PSMA, 18F-rhPSMA-7, in Patients with Prostate Cancer
So Won Oh, Alexander Wurzer, Eugene J. Teoh, Sohee Oh, Thomas Langbein, Markus Krönke, Michael Herz, Saskia Kropf, Hans-Jürgen Wester, Wolfgang A. Weber, Matthias Eiber
Journal of Nuclear Medicine May 2020, 61 (5) 702-709; DOI: 10.2967/jnumed.119.234609
Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of a Novel Radiohybrid PSMA, 18F-rhPSMA-7, in Patients with Prostate Cancer
So Won Oh, Alexander Wurzer, Eugene J. Teoh, Sohee Oh, Thomas Langbein, Markus Krönke, Michael Herz, Saskia Kropf, Hans-Jürgen Wester, Wolfgang A. Weber, Matthias Eiber
Journal of Nuclear Medicine May 2020, 61 (5) 702-709; DOI: 10.2967/jnumed.119.234609
Jump to section
Related Articles
Cited By...
- Validation of 18F-rhPSMA-7 and 18F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer
- Synthesis and Preclinical Evaluation of 177Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer
- Utility of 18F-rhPSMA-7.3 PET for Imaging of Primary Prostate Cancer and Preoperative Efficacy in N-Staging of Unfavorable Intermediate- to Very High-Risk Patients Validated by Histopathology
- 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study
- Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
- Comparative Preclinical Biodistribution, Dosimetry, and Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer Using 19F/177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T
- Safety, Biodistribution, and Radiation Dosimetry of 18F-rhPSMA-7.3 in Healthy Adult Volunteers
- Histologically Confirmed Diagnostic Efficacy of 18F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate Cancer